首页 > 市场调查报告书 > 医疗设备

心血管设备

市场调查报告书

商品编码

1542476

全球心臟再同步治疗设备市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Cardiac Resynchronization Therapy Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 141 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球心臟再同步治疗设备市场需求预计将从 2023 年的 50.7 亿美元增至 2032 年的近 80.9 亿美元，2024-2032 年研究期间复合年增长率为 5.32%。

心臟再同步治疗设备是一种小型电子设备，透过手术植入皮下以帮助两个心室一起收缩。该装置使用电脉衝来使心臟以正常速度跳动。它们也称为起搏器。 CRT 设备透过提高心臟效率和增加血流量来帮助心臟病患者。心律调节器触发心室以更协调的方式收缩，从而改善心臟的血液泵送。

市场动态

全球心血管疾病负担的增加正在推动心臟再同步治疗设备的成长。心血管疾病是全球第一大死因，估计每年夺走 1,790 万人的生命。作为改善症状的治疗措施，正在取得许多进展：即开发心外膜和心内膜引线、开发旋入式引线、改进引线材料和尖端形状、类固醇洗脱引线以及延长电池寿命生活。预期寿命和健康保险的成长预计将加速治疗过程，从而增加对 CRT 设备的需求。然而，与 CRT 设备植入相关的高成本手术预计将限制市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球心臟再同步治疗设备市场的各个细分市场进行了包容性评估。心臟再同步治疗设备产业的成长和趋势为本研究提供了整体方法。

市场区隔

心臟再同步治疗设备市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按产品分类

CRT-去颤器
CRT心律调节器

按最终用途

医院
心臟中心
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲心臟再同步治疗设备市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。心臟再同步治疗设备市场的主要参与者包括美敦力（Medtronic）、雅培（Abbott）、波士顿科学公司（Boston Scientific Corporation）、Biotronik SE & Co. KG、微创科学公司（MicroPort Scientific Corporation）、Livanova Plc。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 8 章：心臟再同步治疗设备公司的竞争格局

心臟再同步治疗设备市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 9 章：公司简介

顶级公司市占率分析
市场集中度
Medtronic

公司概况
公司收入
产品
最新动态

Abbott

公司概况
公司收入
产品
最新动态

Boston Scientific Corporation

公司概况
公司收入
产品
最新动态

Biotronik SE & Co. KG

公司概况
公司收入
产品
最新动态

MicroPort Scientific Corporation

公司概况
公司收入
产品
最新动态

Livanova Plc

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11212560

The global demand for Cardiac Resynchronization Therapy Devices Market is presumed to reach the market size of nearly USD 8.09 Billion by 2032 from USD 5.07 Billion in 2023 with a CAGR of 5.32% under the study period 2024-2032.

Cardiac resynchronization therapy devices are a small electronic device that is surgically implanted under the skin to help both ventricles contract together. This device uses electrical pulses to punctuate the heart to beat at a normal rate. They are also called pacemakers. CRT devices help heart patient by improving the heart's efficiency and increasing blood flow. The pacemaker triggers ventricles to contract in a more coordinated way, which improves the pumping of blood out of the heart.

MARKET DYNAMICS

Rising global burden of cardiovascular diseases is driving the growth of cardiac resynchronization therapy devices. Cardiovascular diseases are the number one cause of death globally, taking an estimated 17.9 million lives each year. Many advances are being made as a therapeutic measure to improve the symptoms: namely, the development of the epicardial and endocardial leads, development of a screw-in lead, improvements in lead material and tip shape, a steroid-eluting lead, and prolong battery life. The growing life expectancy and health insurance are anticipated to accelerate the treatment procedure, thus the demand for CRT devices. However, high-cost surgery associated with CRT devices implant is projected to restrain the growth of the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cardiac Resynchronization Therapy Devices. The growth and trends of Cardiac Resynchronization Therapy Devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cardiac Resynchronization Therapy Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

CRT-Defibrillator
CRT-Pacemaker

By End-use

Hospital
Cardiac Center
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cardiac Resynchronization Therapy Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cardiac Resynchronization Therapy Devices market include Medtronic, Abbott, Boston Scientific Corporation, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Livanova Plc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CARDIAC RESYNCHRONIZATION THERAPY DEVICES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By End-use
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. CRT-Defibrillator Historic and Forecast Sales By Regions
5.4. CRT-Pacemaker Historic and Forecast Sales By Regions

6. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET ANALYSIS BY END-USE

6.1. Overview By End-use
6.2. Historical and Forecast Data Analysis By End-use
6.3. Hospital Historic and Forecast Sales By Regions
6.4. Cardiac Center Historic and Forecast Sales By Regions
6.5. Others Historic and Forecast Sales By Regions

7. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE CARDIAC RESYNCHRONIZATION THERAPY DEVICES COMPANIES

8.1. Cardiac Resynchronization Therapy Devices Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF CARDIAC RESYNCHRONIZATION THERAPY DEVICES INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Medtronic
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Abbott
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Boston Scientific Corporation
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Biotronik SE & Co. KG
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. MicroPort Scientific Corporation
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Livanova Plc
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Product (USD MN)
CRT-Defibrillator Market Sales By Geography (USD MN)
CRT-Pacemaker Market Sales By Geography (USD MN)
Analysis By End-use (USD MN)
Hospital Market Sales By Geography (USD MN)
Cardiac Center Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Cardiac Resynchronization Therapy Devices Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Cardiac Resynchronization Therapy Devices Report
Market Research Process
Market Research Methodology
Global Cardiac Resynchronization Therapy Devices Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Product
Market Attractiveness Analysis By End-use
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Product (USD MN)
CRT-Defibrillator Market Sales By Geography (USD MN)
CRT-Pacemaker Market Sales By Geography (USD MN)
Global Market Analysis By End-use (USD MN)
Hospital Market Sales By Geography (USD MN)
Cardiac Center Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis